Flavonoid-Rich Ethanol Extract from the Leaves of Diospyros kaki Attenuates D-Galactose-Induced Oxidative Stress and Neuroinflammation-Mediated Brain Aging in Mice
Aging is a major factor that contributes to neurological impairment and neuropathological changes, such as inflammation, oxidative stress, neuronal apoptosis, and synaptic dysfunction. Flavonoids act as protective antioxidant and anti-inflammatory agents against various age-related neurodegenerative diseases. Here, we investigated the protective effect and mechanisms of the flavonoid-rich ethanol extract from the leaves of Diospyros kaki (FELDK) in the cortex and hippocampus of D-galactose- (gal-) aged mice. Our results showed that FELDK treatment restored memory impairment in mice as determined by the Y-maze and Morris water maze tests. FELDK decreased oxidative stress levels via inhibiting reactive oxygen species (ROS) and malondialdehyde (MDA) production and elevating antioxidative enzymes. FELDK also alleviated D-gal-induced neuroinflammation via suppressing the expression of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) and activating microgliosis and astrocytosis, nuclear factor kappa B (NF-κB) nuclear translocation, and downstream inflammatory mediators. Moreover, FELDK inhibited the phosphatidylinositol 3-kinase (PI3K)/Akt and C-jun N-terminal kinase (JNK) apoptotic signaling pathways and ameliorated the impairment of synapse-related proteins. Hence, these results indicate that FELDK exerts neuroprotective effects on D-gal-induced brain aging. Thus, FELDK may be a potential therapeutic strategy for preventing and treating age-related neurodegenerative diseases such as Alzheimer’s disease.
Top-30
Journals
|
1
2
3
4
|
|
|
Journal of Functional Foods
4 publications, 8.89%
|
|
|
International Journal of Molecular Sciences
3 publications, 6.67%
|
|
|
Molecules
2 publications, 4.44%
|
|
|
Nutrients
2 publications, 4.44%
|
|
|
Biomedicine and Pharmacotherapy
2 publications, 4.44%
|
|
|
Ecotoxicology and Environmental Safety
2 publications, 4.44%
|
|
|
Phytomedicine
2 publications, 4.44%
|
|
|
Journal of Agricultural and Food Chemistry
2 publications, 4.44%
|
|
|
Journal of Pineal Research
2 publications, 4.44%
|
|
|
Food and Function
2 publications, 4.44%
|
|
|
Aging
1 publication, 2.22%
|
|
|
Medicine (United States)
1 publication, 2.22%
|
|
|
Frontiers in Physiology
1 publication, 2.22%
|
|
|
Frontiers in Pharmacology
1 publication, 2.22%
|
|
|
Fish and Shellfish Immunology
1 publication, 2.22%
|
|
|
Brain Research
1 publication, 2.22%
|
|
|
Neuroscience Research
1 publication, 2.22%
|
|
|
Journal of HerbMed Pharmacology
1 publication, 2.22%
|
|
|
Experimental Gerontology
1 publication, 2.22%
|
|
|
Pharmacological Research
1 publication, 2.22%
|
|
|
Journal of Food Biochemistry
1 publication, 2.22%
|
|
|
Phytotherapy Research
1 publication, 2.22%
|
|
|
Biotechnology Progress
1 publication, 2.22%
|
|
|
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
1 publication, 2.22%
|
|
|
Neurochemistry International
1 publication, 2.22%
|
|
|
Evidence-based Complementary and Alternative Medicine
1 publication, 2.22%
|
|
|
Scientific Reports
1 publication, 2.22%
|
|
|
Biomedical and Pharmacology Journal
1 publication, 2.22%
|
|
|
Molecular Neurobiology
1 publication, 2.22%
|
|
|
Brazilian Archives of Biology and Technology
1 publication, 2.22%
|
|
|
1
2
3
4
|
Publishers
|
2
4
6
8
10
12
14
16
18
|
|
|
Elsevier
17 publications, 37.78%
|
|
|
MDPI
7 publications, 15.56%
|
|
|
Wiley
6 publications, 13.33%
|
|
|
Frontiers Media S.A.
2 publications, 4.44%
|
|
|
American Chemical Society (ACS)
2 publications, 4.44%
|
|
|
Springer Nature
2 publications, 4.44%
|
|
|
Royal Society of Chemistry (RSC)
2 publications, 4.44%
|
|
|
Impact Journals
1 publication, 2.22%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 2.22%
|
|
|
Maad Rayan Publishing Company
1 publication, 2.22%
|
|
|
Taylor & Francis
1 publication, 2.22%
|
|
|
Hindawi Limited
1 publication, 2.22%
|
|
|
Oriental Scientific Publishing Company
1 publication, 2.22%
|
|
|
SciELO
1 publication, 2.22%
|
|
|
2
4
6
8
10
12
14
16
18
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.